Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Network Covalent Solids02:18

Network Covalent Solids

16.2K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Protein Networks02:26

Protein Networks

4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Protein Networks02:26

Protein Networks

2.9K
2.9K
Structures of Solids02:22

Structures of Solids

17.9K
Solids in which the atoms, ions, or molecules are arranged in a definite repeating pattern are known as crystalline solids. Metals and ionic compounds typically form ordered, crystalline solids. A crystalline solid has a precise melting temperature because each atom or molecule of the same type is held in place with the same forces or energy. Amorphous solids or non-crystalline solids (or, sometimes, glasses) which lack an ordered internal structure and are randomly arranged. Substances that...
17.9K
Protein and Protein Structure02:15

Protein and Protein Structure

88.2K
Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme...
88.2K
Dimensional Analysis03:40

Dimensional Analysis

64.9K
Dimensional analysis, also known as the factor label method, is a versatile approach for mathematical operations. The main principle behind this approach is: the units of quantities must be subjected to the same mathematical operations as their associated numbers. This method can be applied to computations ranging from simple unit conversions to more complex and multi-step calculations involving several different quantities and their units.
Conversion Factors and Dimensional Analysis
The unit...
64.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

SEMIPARAMETRIC ANALYSIS OF INTERVAL-CENSORED DATA SUBJECT TO INACCURATE DIAGNOSES WITH A TERMINAL EVENT.

The annals of applied statistics·2026
Same author

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

The annals of applied statistics·2026
Same author

Asymptotic Inference for Multi-Stage Stationary Treatment Policy with Variable Selection.

Journal of machine learning research : JMLR·2026
Same author

Data fusion methods for the heterogeneity of treatment effect and confounding function.

Bernoulli : official journal of the Bernoulli Society for Mathematical Statistics and Probability·2026
Same author

Leveraging precision medicine analytics to optimize inflammation reduction and enhance physical function in older adults.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026

Related Experiment Video

Updated: Feb 6, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.3K

Constructing disease onset signatures using multi-dimensional network-structured biomarkers.

Xiang Li1, Donglin Zeng2, Karen Marder3

  • 1Statistics and Decision Sciences, Janssen Research & Development, LLC, Raritan, NJ, USA.

Biostatistics (Oxford, England)
|August 8, 2018
PubMed
Summary

Developing new therapies for neurodegenerative diseases requires early diagnosis. This study introduces a novel biomarker model to identify pre-symptomatic individuals, improving clinical trial recruitment for conditions like Huntington

Keywords:
Clinical trial designLarge-scale biomarkersLocally varying effectNetwork regularizationNeurological disorders

More Related Videos

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.3K
Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke
06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

1.3K

Related Experiment Videos

Last Updated: Feb 6, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.3K
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.3K
Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke
06:37

Electroencephalography Network Indices as Biomarkers of Upper Limb Impairment in Chronic Stroke

Published on: July 14, 2023

1.3K

Area of Science:

  • Neuroscience
  • Biostatistics
  • Medical Imaging

Background:

  • Effective treatments for neurodegenerative disorders necessitate intervention before symptom onset.
  • Current diagnostic methods for neurological conditions primarily rely on clinical symptoms, identifying patients late in the disease course.
  • Early detection of pathological changes through biomarkers is crucial for timely diagnosis and recruiting pre-symptomatic individuals for prevention trials.

Purpose of the Study:

  • To develop and validate a novel statistical model for constructing biomarker signatures to predict time to disease onset in neurodegenerative disorders.
  • To integrate information on individual biomarker effects varying with baseline disease stage and network structures connecting biomarkers.
  • To enhance early diagnosis and facilitate the recruitment of pre-symptomatic subjects for clinical trials.

Main Methods:

  • Proposed a varying-coefficient hazards model to account for non-linear disease stage effects and network-based biomarker interactions.
  • Employed kernel smoothing of a regularized local partial likelihood for estimation and feature selection.
  • Developed an efficient algorithm for model fitting and analysis.

Main Results:

  • Numerical simulations demonstrated superior performance and computational efficiency compared to existing methods.
  • The model successfully identified structural network signatures associated with premanifest Huntington's disease (HD).
  • Analysis provided new insights into early pathological changes in HD.

Conclusions:

  • The proposed varying-coefficient hazards model effectively leverages biomarker network structures and baseline disease stage information for improved prediction of disease onset.
  • The method offers significant advancements in statistical modeling for neurodegenerative disease research.
  • Application to Huntington's disease highlights the potential for informing clinical trial design and identifying pre-symptomatic individuals.